Stay updated with breaking news from Thyroid Disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The atezolizumab-bevacizumab combination is the first to show efficacy in the adjuvant setting after HCC resection for patients at high risk for recurrence, but the overall survival benefit is unclear.
Trying to lose weight unsuccessfully? Apart from getting older, there are a few important reasons why you have not been able to shed kilos despite following a regimented daily routine. According to health experts, these can range from a variety of underlying ailments like PCOS, hypothyroid, insomnia, etc. Read on to know more about these. , Health News, Times Now
Over the past 30 years, survival of patients with de novo metastatic cancers shows divergent trends, with substantial gains against some cancers but limited or no progress against others.
Three of the comorbidities examined appeared to be causally associated with an increased risk of IPF.
Reducing parathyroid hormone levels surgically in people with primary hyperparathyroidism improved cognition scores but had no significant effect on sleep quality.